The ECFS-CTN cannot guarantee that the information provided here is comprehensive. Please go to the ClinicalTrials.gov link for detailed and up-to-date information on study background, eligibility criteria, study design, outcome measures, study status, participating sites, sponsor contact information and timelines.
You can also contact the CTN coordinating centre for additional information: ECFS-CTN@uzleuven.be (link sends e-mail)
| Study Name on ClinicalTrials.gov (link is external) | Rollover Study of Ivacaftor in Subjects With Cystic Fibrosis and a Non G551D CFTR Mutation (KONTINUE) |
|---|---|
| Study Drug | Ivacaftor (VX770) |
| Type of Study Drug | CFTR Modulation |
| Study Title | A Phase 3, Two-Arm, Rollover Study to Evaluate the Safety of Long Term Ivacaftor Treatment in Subjects 6 Years of Age and Older with Cystic Fibrosis and a Non-G551D CFTR Mutation |
| Study Phase | 3 |
| Study Sponsor | Vertex |
| Participating ECFS-CTN sites | Belgium: Leuven France: Lyon, Montpellier, West-Paris (Debré) UK: Belfast |
| Age | 6 years and older |